Fundraising Fox
Virtual Incision
Lincoln, US · Founded 2006 · Delaware corporation · 32 employees on LinkedIn · 7 known investors
Find your way into Virtual Incision
Sign up to see every warm intro you have to Virtual Incision
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Virtual Incision team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure. The company targets patients, surgeons, and healthcare facilities in the surgical robotics and medical device market.
Founders & leadership
Virtual Incision was founded in 2006 by Dmitry Oleynikov and Shane Farritor.
DO
Dmitry OleynikovCo-founder
SF
Shane FarritorCo-founder
JM
James M. AlecxihNamed on SEC filing
RL
Robert LaridNamed on SEC filing
AK
Amy KobeNamed on SEC filing
Board
TS
FR
Fred RobertsonBoard director
TL
Tao LinBoard director
FP
Fernando PachecoBoard MemberFernando Pacheco is Director at Virtual Incision, which develops MIRA, a miniaturized robotic-assisted surgery system for hospitals. He previously worked in venture capital, leading dealflow, due diligence, and investments in growth-stage medical technology companies.
Investors · 7
Arboretum Ventureslisted by Arboretum VenturesAnn Arbor · $5M – $15Mvia Tom Shehab · board
How we know: Arboretum Ventures's portfolio page · board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Baird Capitallisted by Baird CapitalChicago
How we know: Baird Capital's portfolio page · a partner's Signal profile · funding news · bairdcapital.com · Not right? Tell us
Endeavour Visionlisted by Endeavour VisionGeneva
How we know: funding news · bairdcapital.com · Not right? Tell us
Also in the syndicate · 1
Bluestem Capital
Reported raises · per SEC filings
Form D private placements$134.1M disclosed across 9 of 10 rounds · 2015–2026
▶$35.1MraisedOct 2026 · 60 investors · BiotechnologyRule 506(b)
▶$35.1MraisedOct 2026 · 60 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James M. AlecxihExecutive Officer, Director
- Robert LaridExecutive Officer
- Tyler StowaterDirector
- Fernando PachecoDirector
- Amy KobeDirector
- Shahryar OveissiDirector
- Offering amount
- $80.1M
- Amount sold
- $35.1M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.9MraisedMay 2025 · 62 investors · BiotechnologyRule 506(b)
▶$7.9MraisedMay 2025 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom ShehabDirector
- Fred RobertsonDirector
- Tao LinDirector
- John P. MurphyExecutive Officer, Director
- Fernando PachecoDirector
- Mukund SrinivasanExecutive Officer
- Tyler StowaterDirector
- Offering amount
- $25M
- Amount sold
- $7.9M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJun 2023 · 33 investors · BiotechnologyRule 506(b)
▶$11MraisedJun 2023 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fernando PachecoDirector
- John P. MurphyExecutive Officer, Director
- Tao LinDirector
- Tyler StowaterDirector
- Mukund SrinivasanExecutive Officer
- Fred RobertsonDirector
- Offering amount
- $22.5M
- Amount sold
- $11M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$46.6MraisedDec 2021 · 62 investors · BiotechnologyRule 506(b)
▶$46.6MraisedDec 2021 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rob BarmannDirector
- Lewei WangDirector
- Amy KobeDirector
- John P. MurphyExecutive Officer, Director
- Tyler StowaterDirector
- Offering amount
- $46.6M
- Amount sold
- $46.6M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedOct 2021 · 15 investors · BiotechnologyRule 506(b)
▶$4MraisedOct 2021 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lewei WangDirector
- Mike JerstadDirector
- Shane FarritorExecutive Officer, Director
- John P. MurphyExecutive Officer, Director
- Tyler StowaterDirector
- Steve KirbyDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.1MraisedOct 2019 · 14 investors · BiotechnologyRule 506(b)
▶$10.1MraisedOct 2019 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shane FarritorExecutive Officer, Director
- John P. MurphyExecutive Officer, Director
- Sandy HorstDirector
- Steve KirbyDirector
- Mike JerstadDirector
- Shi ShenghaoDirector
- Offering amount
- $25M
- Amount sold
- $10.1M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedAug 2019 · 5 investors · BiotechnologyRule 506(b)
▶$2.3MraisedAug 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shane FarritorExecutive Officer, Director
- Steve KirbyDirector
- John P. MurphyExecutive Officer, Director
- Shi ShenghaoDirector
- Sandy HorstDirector
- Mike JerstadDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.3MraisedDec 2017 · BiotechnologyRule 506(b)
▶$15.3MraisedDec 2017 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sandy HorstDirector
- John MurphyExecutive Officer, Director
- Shane FarritorExecutive Officer, Director
- Steve KirbyDirector
- Mike JerstadDirector
- Offering amount
- $18.3M
- Amount sold
- $15.3M
- Minimum investment
- $65.2K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
IntuitiveIntuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.
Vicarious SurgicalVicarious Surgical develops a surgical robot for minimally invasive laparoscopic procedures, providing surgeons with 3D visualization and precise control. The system, which has received FDA Breakthrough Device Designation, targets hospitals, surgeons, and patients seeking advanced surgical care.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Moon SurgicalMoon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures. The company, with a French-American team, has received FDA clearance and CE mark for its system.
Horizon Surgical SystemsHorizon Surgical Systems develops surgical robotics for ophthalmic procedures, with a focus on improving cataract surgery. Its technology, spun out of research at UCLA, uses AI-trained imaging to make cataract care more precise and consistent.
UclahealthUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.
Companies working in the same space as Virtual Incision.
In the news
Frequently asked questions
- What does Virtual Incision do?
- Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure. The company targets patients, surgeons, and healthcare facilities in the surgical robotics and medical device market.
- Who founded Virtual Incision?
- Virtual Incision was founded by Dmitry Oleynikov, Shane Farritor in 2006.
- Who are Virtual Incision's investors?
- Virtual Incision's investors include Arboretum Ventures, Baird Capital, Endeavour Vision, Invest Nebraska, InVivium Capital, PrairieGold Venture Partners.
- How much funding has Virtual Incision raised?
- Virtual Incision has disclosed $134.1M raised across 9 of its 10 known rounds.
- Where is Virtual Incision headquartered?
- Virtual Incision is headquartered in Lincoln, US.